Dr. Michael Blaese
Dr. Michael Blaese (fourth from l), chief of the Clinical Gene Therapy Branch at the National Human Genome Research Institute, is this year's winner of the Federal Laboratory Consortium (FLC) Award for Excellence in Technology Transfer. The annual award recognizes researchers at government agencies across the country who have made significant contributions in technology transfer through commercialization of their work. "Through his discoveries and efforts in technology transfer, Dr. Blaese laid the foundation for an entire industry developed around gene therapy," his citation reads. "In addition, his work shows great promise in the treatment of a variety of genetic diseases, thus relieving great pain and suffering for many people all over the world." On hand to congratulate him were (from l) Dr. Maria Freire, director, NIH Office of Technology Transfer; Dr. Francis Collins, NHGRI director; Dr. Ron King, chief of NHGRI's Technology Transfer Office; Dr. Michael Gottesman, NIH deputy director for intramural research; and Tyrone Taylor, FLC representative.
NIH'ers Earn HHS Honor Awards
Several NIH employees were among those honored by Secretary Donna Shalala and the Department of Health and Human Services at the recent DHHS Honor Awards ceremony. The following NIH honorees received the Secretary's Award for Distinguished Service: Matilde Alvarado, Dr. Carlos Crespo, Claire Lane, Eileen Newman and Laina Pack of the NHLBI Latino Community CVD Prevention and Outreach Initiative Team for "exceptional teamwork in developing and evaluating cardiovascular disease prevention and control strategies to reach Hispanic audiences"; Dr. Marian Willinger and Ruth Dubois of the NICHD SIDS "Back-to-Sleep" Campaign Team for "developing information on [sudden infant death syndrome] risks and translating it to health professionals and the public through a 'Back-to-Sleep' campaign that reduced SIDS deaths by 30 percent"; Dr. William Duncan of NIAID for "vision and leadership in the development and management of a comprehensive program in AIDS therapeutics research"; Dr. Sanford Markey of NIMH for "distinguished and unique contributions to the identification, quantification and elucidation of the biological and clinical relevance of neuroactive molecules"; and Dr. Susan Swedo of NIMH for "successfully leading the NIMH Intramural Research Program while serving in an acting period of transition."
Dr. Terry Burke
Dr. Terry Burke, a research chemist and principal investigator in the National Cancer Institute's Laboratory of Medicinal Chemistry, was recently presented the 1996 Sato International Award by the Pharmaceutical Society of Japan in a ceremony held in Tokyo. He delivered an award address at the 117th annual meeting of the society. The yearly award recognizes scientific achievement in medicinal chemistry, and alternates between a Japanese and American awardee.
Up to Top